Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dimiter V. Tassev"'
Autor:
Richard J. O'Reilly, Qi Zhao, Tzu-Yun Kuo, Hong-fen Guo, Aisha Hasan, Nai-Kong V. Cheung, Dimiter V. Tassev, Mahiuddin Ahmed
Publikováno v:
Leukemia. 29:2238-2247
WT1126 (RMFPNAPYL) is a human leukocyte antigen-A2 (HLA-A2) restricted peptide derived from Wilms tumor protein (WT1), which is widely expressed in a broad spectrum of leukemias, lymphomas and solid tumors. A novel T-cell-receptor (TCR)-like single c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7fad077009eeefcdc9083285593ba53
https://doi.org/10.1038/leu.2015.125
https://doi.org/10.1038/leu.2015.125
Publikováno v:
Oncoimmunology
Murine IgG3 anti-GD2 antibody m3F8 has shown anti-neuroblastoma activity in Phase I/II studies, where antibody-dependent cell-mediated cytotoxicity (ADCC) played a key role. Humanization of m3F8 should circumvent human anti-mouse antibody (HAMA) resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272a558d9d6f0951c75b2933ead9f09e
https://doi.org/10.4161/onci.19864
https://doi.org/10.4161/onci.19864
Autor:
Dimiter V. Tassev, Nai-Kong V. Cheung
Publikováno v:
Expert Opinion on Biological Therapy. 9:341-353
Background: About 1.4 million new cancer cases are expected to be diagnosed in the US in 2008 and the overall costs of cancer treatment is estimated at > $200 billion per year. Over half a million people will die from cancer each year. Monoclonal ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be3f371336dbf527e2c6ab67b62b02bf
https://doi.org/10.1517/14712590802715764
https://doi.org/10.1517/14712590802715764
Autor:
Tzu-Yun Kuo, Annamalai Selvakumar, Richard J. O'Reilly, Qi Zhao, Aisha Nasreen Hasan, Dimiter V. Tassev, Nai-Kong V. Cheung
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(2):S132-S133
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4953b85b595bcde6e61368c0077da17c